FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment Print this page SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters,… Read More »